Symbol="CAPR"
AssetType="Common Stock"
Name="Capricor Therapeutics Inc"
Description="Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California."
CIK="1133869"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="8840 WILSHIRE BLVD, 2ND FLOOR, BEVERLY HILLS, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="170901000"
EBITDA="-29662628"
PERatio="None"
PEGRatio="0"
BookValue="0.106"
DividendPerShare="0"
DividendYield="0"
EPS="-0.92"
RevenuePerShareTTM="0.378"
ProfitMargin="0"
OperatingMarginTTM="-3.223"
ReturnOnAssetsTTM="-0.366"
ReturnOnEquityTTM="-2.724"
RevenueTTM="9455600"
GrossProfitTTM="1746400"
DilutedEPSTTM="-0.92"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="61.69"
PriceToBookRatio="6.5"
EVToRevenue="35.42"
EVToEBITDA="-2.043"
Beta="3.963"
num_52WeekHigh="8.22"
num_52WeekLow="3.3"
num_50DayMovingAverage="5.36"
num_200DayMovingAverage="4.512"
SharesOutstanding="25776900"
DividendDate="2019-06-05"
ExDividendDate="None"
symbol="CAPR"
open="6.69"
high="6.85"
low="6.30"
price="6.48"
volume="224069.00"
latest_trading_day="2023-08-31"
previous_close="6.63"
change="-0.15"
change_percent="-2.2624%"
aroon_positive_momentum_days="73"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="73"
Volume_recent_avg="100016"
Change_recent_avg="0.02"
Delta_recent_avg="0.29"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="0.33"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="73"
Aroon_momentum_negative="27"
image_negative_thumbnail_id_1="505"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0100.jpeg"
image_negative_thumbnail_id_2="495"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0110.jpeg"
image_neutral_thumbnail_id_1="541"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_neutral_thumbnail_id_2="545"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_positive_thumbnail_id_1="675"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0033.jpeg"
image_positive_thumbnail_id_2="667"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0041.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
